分析证书 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-12-30. Numbers and descriptions here follow the published literature rather than marketing material.
Retatrutide is an investigational synthetic peptide developed under the code LY3437943, with a backbone derived from glucose-dependent insulinotropic polypeptide. Several non-proteinogenic residues, including alpha-aminoisobutyric acid, appear in that backbone, and a fatty diacid side chain attached through a linker extends circulation time. The molecule carries roughly thirty-nine amino acid units and a total mass near 4.7 kilodaltons. Administration is by subcutaneous injection once weekly. Published work uses both the name retatrutide and the code LY3437943.
Pharmacologically the compound activates three receptors: GLP-1, GIP, and glucagon. GLP-1 and GIP signaling contribute to glucose-dependent insulin release, delayed gastric emptying, and reduced appetite, while glucagon receptor activation is associated with increased energy expenditure and hepatic fat oxidation. The single-molecule design is intended to keep these activities in one peptide rather than combining separate agents. Relative activity at each receptor differs, and the balance between them is a central question in interpretation. The glucagon component is partly offset by incretin-mediated insulin secretion, an interaction that remains incompletely characterized.
The intended pharmacology combines three signals in one molecule. GLP-1 receptor activation reduces appetite and slows gastric emptying, effects already exploited by approved incretin-based therapies. GIP receptor engagement is associated with improved insulin sensitivity and with direct effects on adipose tissue, although how much it contributes to overall outcomes is still debated. Glucagon receptor agonism raises energy expenditure and supports hepatic lipid handling, a mechanism that also tends to increase glucose output. The triple profile is hypothesized to produce a larger metabolic effect than single or dual agonism, but the relative weight of each receptor in humans is not settled.
Human evidence remains limited to controlled studies. A phase 2 trial in adults with obesity reported large, dose-dependent reductions in body weight over 48 weeks, with gastrointestinal events as the most frequently recorded adverse effect. Phase 3 programs designated TRIUMPH, for obesity, and TRANSCEND, for type 2 diabetes, are intended to confirm efficacy and to characterize safety in larger populations. Related studies are examining conditions such as knee osteoarthritis in people with obesity and metabolic liver disease. Open questions include long-term tolerability, effects on lean mass, and what happens after treatment is stopped.
Retatrutide is an investigational synthetic peptide that acts on three receptor targets at once: glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon. It is developed by Eli Lilly and appears in the literature and in trial registries under the code LY3437943. The molecule belongs to a class of engineered peptides designed to resist rapid breakdown and permit infrequent subcutaneous administration. No regulatory agency has approved it for clinical use, and all available human data come from controlled trials rather than from routine practice.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide of about 39 residues | Backbone derived from a GIP sequence |
| Molecular mass | Approximately 4.7 kDa | Peptide chain plus fatty diacid moiety |
| Receptor targets | GLP-1, GIP, glucagon | Unimolecular triple agonist |
| Typical storage temperature | 2 to 8 degrees Celsius | Protect from light; avoid repeated freeze-thaw |
| Common analytical method | LC-MS/MS | Used for plasma quantification and purity checks |
稳定性研究一般关注脱酰胺、氧化与聚集三类降解路径。脱酰胺多发生在天冬酰胺残基上，氧化常涉及甲硫氨酸与色氨酸，聚集则与浓度、温度以及容器界面接触有关。强制降解实验用于识别分子中较敏感的位点。这些结果会直接影响储存条件的设定与有效期的判断。
冻干粉通常在低温环境下保存，复溶之后需要按指定条件在较短时间内使用。反复冻融和剧烈振荡可能促进聚集，低吸附容器则能减少多肽在管壁上的损失。批号、日期与处理条件的完整记录，是后续复核与问题追溯的基础。
供应环节涉及来源核实与文件审核两类工作。分析证书、批次记录以及第三方检测报告构成常见的可追溯材料。来源不清的样品很难确认身份与纯度，因此核实步骤在实际操作中具有明确意义。缺少方法细节的报告通常无法复核。
Clinical development has advanced through phase 2 trials in adults with obesity and type 2 diabetes. Reported phase 2 results described substantial average weight reduction over roughly forty-eight weeks of weekly dosing. A phase 3 program is ongoing to confirm efficacy and assess long-term safety. Because the compound has not received regulatory approval, it is not available as a prescription product. Public discussion of retatrutide often conflates trial findings with marketed status, an important distinction when interpreting coverage of the topic.
Retatrutide is a synthetic peptide developed as a single molecule that activates three distinct hormone receptors: GLP-1, GIP, and glucagon. The compound carries the internal designation LY3437943 and was engineered by modifying the backbone of glucose-dependent insulinotropic polypeptide. Its sequence incorporates non-natural amino acids and a fatty acid side chain that extends circulation time. The triple-agonist design aims to combine appetite suppression, improved insulin response, and increased energy expenditure in one agent. Published reports describe it as an investigational product rather than an approved medicine.
开发进程从早期单次和多次给药研究推进至大规模后期试验。公开报告显示，参与者在体重和相关代谢指标上出现变化，但完整数据需经同行评审并接受独立复核。试验设计通常包括随机、双盲和对照设置，以区分药物效应与行为干预。监管提交和标签范围尚未确定；长期维持效果与心血管结局仍是开放问题。
与仅靶向单一受体的同类药物相比，瑞他鲁肽增加胰高血糖素受体成分，理论上可提高能量消耗并改变脂肪分布。临床中观察到的体重变化是否主要来自该额外机制，目前尚无定论。胃肠道反应是该类药物常见不良事件，试验中通过剂量递增和监测进行管理。停药后体重反弹、个体差异和长期耐受性仍需更多数据。
瑞他鲁肽是一种在研合成肽，同时作用于胰高血糖素样肽-1、葡萄糖依赖性促胰岛素多肽和胰高血糖素受体。该分子属于多受体激动剂类别，尚未获得任何监管机构的上市批准。当前临床开发主要针对肥胖和2型糖尿病，研究代号为LY3437943。已确立的信息包括受体靶点和部分中期试验结果；最终疗效、长期安全性和适用人群仍属开放问题。
Several questions about the compound remain unresolved. The durability of weight reduction after treatment stops, the frequency of gastrointestinal side effects, and the long-term cardiovascular profile are topics of ongoing study. Regulatory submissions and phase 3 trial outcomes have not been fully reported in the public literature. Because most available data come from controlled trials rather than general-population use, conclusions about effectiveness outside study settings are provisional. The distinction between established findings and open questions matters when interpreting early coverage of the drug.
Retatrutide is an investigational peptide developed by a pharmaceutical company as a multi-receptor agonist for treating obesity and type 2 diabetes. The compound emerged from research into gut-hormone analogues that act on several receptors simultaneously rather than on a single target. Early preclinical work examined how combined activity at three distinct receptors might produce greater metabolic effects than single-receptor compounds. Published phase 2 results have described substantial reductions in body weight among participants, although the compound remains unapproved in most jurisdictions as of the mid-2020s.
=== Cancer === Defection of cells from the normally tight coordination of activity towards an anatomical structure results in cancer; it is thus no surprise that bioelectricity – a key mechanism for coordinating cell growth and patterning – is a target often implicated in cancer and metastasis. Indeed, it has long been known that gap junctions have a key role in carcinogenesis and progression. Channels can behave as oncogenes and are thus suitable as novel drug targets. Recent work in amphibian models has shown that depolarization of resting potential can trigger metastatic behavior in normal cells, while hyperpolarization (induced by ion channel misexpression, drugs, or light) can suppress tumorigenesis induced by expression of human oncogenes. Depolarization of resting potential appears to be a bioelectric signature by which incipient tumor sites can be detected non-invasively. Refinement of the bioelectric signature of cancer in biomedical contexts, as a diagnostic modality, is one of the possible applications of this field. Excitingly, the ambivalence of polarity – depolarization as marker and hyperpolarization as treatment – make it conceptually possible to derive theragnostic (portmanteau of therapeutics with diagnostics) approaches, designed to simultaneously detect and treat early tumors, in this case based on the normalization of the membrane polarization.
A breast implant is a prosthesis used to change the size, shape, and contour of a person's breast. In reconstructive plastic surgery, breast implants can be placed to restore a natural-looking breast following a mastectomy, to correct congenital defects and deformities of the chest wall or, cosmetically, to enlarge the appearance of the breast through breast augmentation surgery. Complications of implants may include breast pain, rashes, skin changes, infection, rupture, cosmetic changes to the breasts such as asymmetry and hardness, and a fluid collection around the breast. A rare complication associated with textured surfaced implants and polyurethane foam-covered implants is a type of lymphoma (cancer of the immune system) known as breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL). There are four general types of breast implants, defined by their filler material: saline solution, silicone gel, structured and composite filler. The saline implant has an elastomer silicone shell filled with sterile saline solution during surgery; the silicone implant has an elastomer silicone shell pre-filled with viscous silicone gel; structured implants use nested elastomer silicone shells and two saline-filled lumen; and the alternative composition implants featured miscellaneous fillers, such as hydrogel, soy oil or polypropylene string. In surgical practice, for the reconstruction of a breast, the tissue expander device is a temporary breast prosthesis used to form and establish an implant pocket for the future permanent breast implant.
==== School grades of children ==== According to a study reported in the NY Post newspaper, 48% of parents reward their children's good grades with cash or something else of meaning. Among many families in the United States, this is controversial. Although psychology experts support the offer of reward for good behavior as a better alternative than the use of punishment for bad behavior, in some circumstances, families cannot afford to give their children an average of 16 dollars for every good grade earned. Alternatives for money include allowing a child extra time on a computer or staying up later than usual. Some psychology experts believe the best reward is praise and encouragement because material rewards can cause long-term negative effects for children. A study, regarding rewards for children, conducted in 1971 by psychologist, Edward L. Deci, at the University of Rochester, is still referenced today. Featured in the New York Times, it focused on the short- and long-term effects of rewards for positive behavior. Deci suggested rewards for positive behavior is an effective incentive for only a short period. At the outset, rewards can support motivation to work hard and strive towards personal goals. However, once rewards cease, children showed less interest in the task relative to participants who never received rewards. Deci pointed out, at a young age, children's natural instinct is to resist people who try to control their behavior, which he cited as support for his conclusion rewards for good behavior have limited effectiveness.
Sunflower, corn, and soybean oil have a higher proportion of omega-6 fatty acids than oils from fish, walnuts, flaxseed, and rapeseed (canola). Omega-6 fatty acids constitute a growing proportion of Americans' fat intake. They have been hypothesized to contribute to several negative health effects, including inflammation and immunodeficiency, but most cardiovascular health researchers believe the data shows that omega-6 fatty acids are safe and healthy for humans. In fact, omega-6 fatty acids are significantly associated with a lowered risk of cardiovascular disease, and the American Heart Association has stated that a reduction in omega-6 fatty acids could lead to an increase, not reduction, in cardiovascular disease. Research indicates that consumption of omega-6 fatty acids has no significant effect on inflammatory bowel disease.
Sources: en.wikipedia.org
The surface tension of liquid ethylene oxide, at the interface with its own vapor, is 35.8 mJ/m2 (0.00079 cal/sq ft) at −50.1 °C (−58.2 °F) and 27.6 mJ/m2 (0.00061 cal/sq ft) at −0.1 °C (31.8 °F). The boiling point increases with the vapor pressure as follows: 57.7 °C (135.9 °F) (2 atm (200 kPa; 29 psi)), 83.6 °C (182.5 °F) (5 atm (510 kPa; 73 psi)), and 114.0 °C (237.2 °F) (10 atm (1,000 kPa; 150 psi)). Viscosity decreases with temperature with the values of 0.577 kPa·s at −49.8 °C (−57.6 °F), 0.488 kPa·s at −38.2 °C (−36.8 °F), 0.394 kPa·s at −21.0 °C (−5.8 °F), and 0.320 kPa·s at 0 °C (32 °F). Between −91 and 10.5 °C (−131.8 and 50.9 °F), vapor pressure p (in mmHg) varies with temperature (T in °C) as
Frank Furedi (born 1947) is a Hungarian Jewish British Canadian academic known for work on sociology of fear, education, therapy culture, paranoid parenting and sociology of knowledge; in 1970s, was member of International Socialists (IS); later formed the Revolutionary Communist Group, and then broke from that to form Revolutionary Communist Tendency, refounded as the Revolutionary Communist Party in 1978; RCP was distinguished by its contrarianism; among its positions were support for IRA and Saddam Hussein Furedi is now associated with the RCP's successor, the web site Spiked Online. Neil Gaiman fantasy writer Uri Geller (Hebrew: אורי גלר; born 20 December 1946 in British Mandate of Palestine Mandatory Palestine (now Israel), of Hungarian Jewish ancestry, is an Israeli-British illusionist, magician, television personality, self-proclaimed psychic and author of over ten books, both fiction and non-fiction. Ernest Gellner social anthropologist, scholar of nationalism and identity, of Austrian Jewish and Czech Jewish origin. Adele Geras, (née Weston; born 15 March 1944) FRSL is an English writer for young children, teens and adults. She has written more than 95 books for children, young adults, and adults.
=== Crop development === Given the enormous damage that citrus canker, citrus greening, bacterial soft rot and wildfire disease cause to food and cash crops each year, there is interest in developing new plant varieties that are more resistant to infection. One possible solution is to enhance the natural defenses of crops using antimicrobial peptides. Necrophagous insects are a rich source of these peptides, and transgenic research in Japan, the USA, and Brazil has shown that sarcotoxin IA (from Sarcophaga peregrina) can help protect orange trees and other crops.
The Managing Committee of the school is headed by the Joint Director of Education of the Directorate of Education, Air Headquarters (R.K. Puram) New Delhi. The Committee consists of some officers of the Indian Air Force and two elected representatives of the teaching staff; one elected representative of the parents, two nominated members each of the Directorate of Education, Delhi Administration and of the Education Advisory Board, Delhi Administration. The Board of Governors, presided over by the Air Officer in charge of Administration, Air Headquarters is the body for all the schools run by the IAF Education Society. The Vice Principal looks after the academics, assisted by the Headmistress of the Junior Wing and the Head of the Department of each faculty. The Administrative Officer cum Bursar and the Accountant, look after the accounts, administration and management.
=== Human trafficking === Human trafficking is a modern form of slavery where people are forced, tricked, or pressured into working or doing sexual acts. It can happen anywhere and affect anyone, no matter their age, race, or background.
Sources: en.wikipedia.org
Skin whitening, also known as skin lightening and skin bleaching, is the practice of using chemical substances in an attempt to lighten the skin or provide an even skin color by reducing the melanin concentration in the skin. Several chemicals have been shown to be effective in skin whitening, while some have proven to be toxic or have questionable safety profiles. This includes mercury compounds which may cause neurological problems and kidney problems. In a number of African countries, above 25% of women regularly use skin-whitening products. In Asia, this number is around 40%. In India, over 50% of skin-care product sales are attributed to skin-lightening formulations. In Pakistan, where skin lightening products are popular, creams have been found to contain toxic levels of hydroquinone and mercury. Efforts to lighten the skin date back to at least the 16th century in Asia. While a number of agents — such as kojic acid and alpha hydroxy acid — are allowed in cosmetics in Europe, a number of others such as hydroquinone and tretinoin are not. While some countries do not allow mercury compounds in cosmetics, others still do, and they can be purchased online.
Ernest William Beckett (1856–1917), who became the 2nd Baron Grimthorpe. Helen Louisa Beckett-Denison (1858–1935). Adeline Gertrude Beckett-Denison (1859–1902), who married Sir Frederick Milner, 7th Baronet. Violet Katharine Beckett-Denison (1860–1883), who married Reginald Walkeline Chandos-Pole, grandson of Leicester Stanhope, 5th Earl of Harrington. Maud Augusta Beckett-Denison (1864–1927), who married Lord Henry Nevill (later 3rd Marquess of Abergavenny). William Gervase Beckett (1866–1937), who became Sir Gervase Beckett, 1st Baronet of Kirkdale Manor. Hon. Rupert Evelyn Beckett (1870–1955), who married Muriel Helen Florence Paget, granddaughter of Henry Paget, 2nd Marquess of Anglesey. Beckett died at the age of 64 when he fell under a train at Wimborne. He had arrived at Wimborne railway station to change trains for Bournemouth, and while waiting, he went for a walk. He was walking beside the track on the way back to the station when a strong wind blew his hat off, and he fell almost immediately under the train. His body was cut to pieces and carried some 56 feet. Following his death, Mrs. Gertrude Beatrice Brinkworth alleged she was his mistress and mother of his adopted children and sued his executors. Some money was paid, but the case came before the court, and the jury declared Mrs. Brinkworth's case to be a 'swindle' and rejected her claims even before the evidence in the case had been completed.
=== Head of intelligence === Noriega proved to be a very capable head of intelligence. During his tenure, he exiled 1,300 Panamanians whom he viewed as threats to the government. He also kept files on several officials within the military, the government, and the judiciary, allowing him to blackmail them later. Noriega also held the positions of head of the political police and head of immigration. His tenure was marked by intimidation and harassment of opposition parties and their leaders. He was described as doing much of Torrijos's "dirty work". For instance, Noriega ordered the death of Jesús Héctor Gallego Herrera, a priest whose work at an agricultural cooperative was seen as a threat by the government. Gallego's body is reported to have been thrown from a helicopter into the sea. He also made an effort during this period to portray Panama as a hub of enforcement against drug smuggling, possibly as a result of pressure from Torrijos. By the early 1970s, American law enforcement officials had reports of Noriega's possible involvement with narcotics trafficking. No formal criminal investigations were begun, and no indictment was brought: according to Dinges, this was due to the potential diplomatic consequences. This evidence included the testimony of an arrested boat courier, and of a drug smuggler arrested in New York. Though Torrijos frequently promised the U.S. cooperation in dealing with drug smuggling, Noriega would have headed any effort at enforcement, and the U.S. began to see Noriega as an obstacle to combatting drug smuggling. Dinges writes that the U.S.
2C-B, also known as 4-bromo-2,5-dimethoxyphenethylamine or by names such as Nexus or Erox, is a psychedelic drug of the phenethylamine and 2C families. The drug is used as a recreational drug and is usually taken orally. 2C-B produces hallucinogenic, mild stimulant, and mild entactogenic-like effects. Its hallucinogenic effects at typical doses are milder than those of other psychedelics like LSD or psilocybin. The drug acts as a potent partial agonist of the serotonin 5-HT2 receptors, including of the serotonin 5-HT2A receptor. It produces psychedelic-like effects in animals. Numerous analogues and derivatives of 2C-B are known, such as DOB, 2C-B-FLY, and 25B-NBOMe among others. 2C-B was developed by Alexander Shulgin in 1974 and was described by him in the scientific literature in 1975. The drug emerged as a novel recreational designer drug and MDMA (ecstasy) substitute in the mid-1980s. Subsequently, it became a controlled substance in the United States in the mid-1990s. 2C-B was one of the first 2C psychedelics to be described. It is the most popular and well-known of the 2C psychedelics and is one of the most widely used designer drugs.
=== Adam Eshel === Adam Eshel (Damon Dayoub) works for Shin Bet, Israel's internal security and counterintelligence service, and is also Ziva David's contact. During Eshel's first appearance, he assists in the investigation into Ilan Bodnar, working with Tony and Ziva. In "Whiskey Tango Foxtrot", Eshel lends his expertise in order to give DiNozzo an insight into Ziva's personal life and current whereabouts. He is mentioned in "Family First", with DiNozzo stating he has asked Eshel about Ziva's current location, but that Adam says he has not had contact with her in over a year. In Season 17, it is revealed that, after Ziva has escaped the mortar attack, she brought Tali to Adam who then brings the child to Orli. Eshel returns in the NCIS Season 17 episode, "The North Pole" where he was captured by henchmen working for terrorist Sahar who has been hunting Ziva and tortured Adam. Despite Gibbs and Ziva's efforts, they arrive too late to save Eshel who ultimately succumbs to his injuries and dies although Eshel tells them that the real Sahar they've been looking for is someone they know before dying, leading the two to realize that the real Sahar is Gibbs's neighbor, Sarah.
Sources: en.wikipedia.org
As of the mid-2020s retatrutide remains investigational and is not an approved medicine in the United States or the European Union. It has been supplied mainly to participants in clinical trials. Labels and availability can change, so regulatory listings should be checked directly.
Dual agonists act at the GLP-1 and GIP receptors, whereas retatrutide adds glucagon receptor activity on the same peptide. This third activity is the main structural and pharmacological distinction discussed in the literature. Direct head-to-head comparisons remain limited.
Reports usually give the study code LY3437943 alongside the name, the dose in milligrams, and the week at which an endpoint was measured. Percent body-weight change is the most frequent headline measure. Units and populations vary, so comparisons across reports require care.
It is an investigational peptide that activates three hormone receptors: GIP, GLP-1 and glucagon. It is being studied mainly for obesity and type 2 diabetes, and it is not approved for any clinical use. Published information comes from controlled trials rather than from general practice.